SCHEMBL4517533

SCHEMBL4517533

O=C(CCS)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
KMO O15229 3/20 0.53
HSD11B1 P28845 1/20 0.49
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
HPGD P15428 1/20 0.47
SRD5A2 P31213 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286984 0.84 TSHR (0.57) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL6998011 0.82 POLB (0.56) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL11392489 0.82 TSHR (0.55) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL727064 0.81 TSHR (0.59) TSHRKMOHSD11B1SRD5A2
SCHEMBL634176 0.81 HSD17B3 (0.55) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL9337894 0.80 THRA (0.59) TSHRKMOHDAC3HDAC4HDAC1
SCHEMBL9015106 0.79 TSHR (0.61) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL2435064 0.79 KDM4E (0.57) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL8072291 0.79 KMO (0.54) TSHRKMOHSD11B1HDAC3HDAC4
SCHEMBL14775644 0.79 TSHR (0.52) TSHRKMOHSD11B1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182121-A1 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-08-18 US claimed
US-6897240-B2 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-05-24 US claimed
US-20040014801-A1 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-01-22 US claimed
US-7495023-B2 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-02-24 US disclosed
US-20050182121-A1 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-08-18 US disclosed
US-6897240-B2 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-05-24 US disclosed
US-20040014801-A1 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014801-A1 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use CTSB, CTSS, CTSL TSHR 2766/4885KMO 2015/4885HSD11B1 3054/4885
US-20050182121-A1 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use CTSB, CTSS, CSTB TSHR 2544/4885KMO 1832/4885HSD11B1 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.